闫潇婷,常 琼

2型糖尿病（T2DM）患者的大血管病变，如心血管疾病、脑血管疾病和外周动脉疾病，是导致其高死亡率的关键因素之一。近年来，甘油三酯葡萄糖指数（TyG指数）作为一种反映胰岛素抵抗（IR）和糖脂代谢紊乱的新型指标，其与T2DM大血管病变的关联受到了广泛关注。本文结合近年的研究进展，系统地综述了TyG指数在大血管病变中的作用机制、临床预测价值以及潜在的应用方向。

2型糖尿病；2型糖尿病大血管病变；甘油三酯葡萄糖指数

[1] WANG L M,PENG W,ZHAO Z P,et al.Prevalence and treatment of diabetes in China,2013-2018[J].JAMA,2021,326(24):2498-2506. [2] 徐冰冰,李肖静,张亚伟.2型糖尿病患者糖尿病慢性并发症现状调查及影响因素[J].华南预防医学,2021,47(1):74-76. [3] PEARSON-STUTTARD J,BENNETT J,CHENG Y J,et al.Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018:an epidemiological analysis of linked primary care records[J].Lancet Diabetes Endocrinol,2021, 9(3):165-173. [4] Guerrero-Romero F,Simental-Mendía LE,González-Ortiz M,et al. The product of triglycerides and glucose,a simple measure of insulin sensitivity.Comparison with the euglycemic-hyperinsulinemic clamp[J].JClin Endocrinol Metab,2010,95(7):3347-3351. [5] YUANT,YANGT,CHENH,etal.New insights into oxida tive stress and inflammation during diabetes mellitus-accel erated athero- sclerosis[J].Redox Biol,2019,20:247-260. [6] POZNYAK A,GRECHKO A V,POGGIO P,et al.The diabetes mellitus-atherosclerosis connection:the role of lipid and glucose metabolism and chronic inflammation[J].Int J Mol Sci,2020,21(5):1835. [7] LA SALA L,PRATTICHIZZO F,CERIELLO A.The link between diabetes and atherosclerosis[J].Eur J Prev Cardiol,2019,26(2_suppl):15-24. [8] Torella D,Gasparri C,Ellison G M,et al.Differential regulation of vascu-lar smooth muscle and end othelial cell proliferation in vitro a nd in vivo by cAMP/PKA-activated p85 alpha PI3K(J).Am J Physiol H eart Circ Physiol,2009;297(6):H2015-25. [9] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2021概要[J].中国循环杂志,2022,37(6):553578 [10] Zhang Y,Ding XS,Hua B,et al.High triglyceride‐glucose index is associated with poor cardiovascular outcomes in nondiabetic patients with acs with LDL‐C below 1.8 mmol/L.J Atheroscler Thromb,2022,29:268‐281. [11] Zhang RT,Shi SS,Chen WH,et al.Independent effects of the triglyceride‐glucose index on all‐cause mortality in critically ill patients with coronary heart disease:analysis of the MIMIC‐III database.Cardiovasc Diabetol,2023,22:10. [12] 张梦玮,徐长江,段洋,等.利用TyG指数评估急性心肌梗死患者的预后[J].中国循证心血管医学杂志,2021,13(4):499-503. [13] 云发超,何静,李奋荣,等.甘油三酯葡萄糖指数对中老年心血管疾病的预测效能研究[J].现代医药卫生,2025,41(01):93-97+103. [14] BROOKS D C,SCHINDLER J L.Management of hyperlipidemia after stroke[J].Curr Treat Options Cardiovasc Med,2019,21(12):93. [15] GONG Q H,ZHANG P,WANG J P,et al.Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance:30-year results of the Da Qing Diabetes Prevention Outcome Study[J].Lancet Diabetes Endocrinol,2019,7(6):452-461. [16] CHEN R,OVBIAGELE B,FENG W W.Diabetes and stroke:epidemiology,pathophysiology,pharmaceuticals and out comes[J].Am J Med Sci,2016,351(4):380-386. [17] Cheng Y,Fang Z,Zhang X,et al.Association triglyeeride glucose-body mass index and cardilar outcomes in patients undergoing percutaneconary intervention:a retrospective study]vasc Diabetol,2023,22(1):75-89. [18] 提衍丽,袁洪宇,王丽娜,等.甘油三酯—葡萄糖指数对脑梗死患者脑血管狭窄程度的预测价值[J].国际神经病学神经外科学杂志,2024,51(1):44-47. [19] GAO X,TONG Z,WU Y,et al.Similarities and differences in peripheral artery disease between China and Western countries[J].J Vasc Surg,2021,74(4):1417-1424. [20] HAMBURG N M,CREAGER M A.Pathophysiology of intermittent claudication in peripheral artery disease[J].Circ J,2017,81(3):281-289. [21] HINCHLIFFE R J,BROWNRIGG J R W,ANDROS G,et al.Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease:a systematic review[J].Diabetes Metabolism Res,2016,32(S1):136-144. [22] BARNES J A,EID M A,CREAGER M A,et al.Epidemi ology and risk of amputation in patients with diabetes mellitus and peripheral artery disease[J].Arterioscler Thromb Vasc Biol,2020,40(8):1808-1817. [23] LATHIEF S,INZUCCHI S E.Approach to diabetes man agement in patients with CVD[J].Trends Cardiovasc Med,2016,26(2):165-179.

点击下载PDF